Rabeprazole sodium Injection 20 mg

  • antisecretory compounds
Category:

Description

Rabeprazole sodium  Injection 20 mg  belongs to a class of antisecretory compounds (substituted benzimidazole proton-pump inhibitors) that do not exhibit anticholinergic or histamine H2-receptor antagonist properties, but suppress gastric acid secretion by inhibiting the gastric H+, K+ATPase at the secretory surface of the gastric parietal cell. Because this enzyme is regarded as the acid (proton) pump within the parietal cell, rabeprazole has been characterized as a gastric proton-pump inhibitor. Rabeprazole blocks the final step of gastric acid secretion. Rabeprazole sodium  Injection 20 mg is used in Short-term treatment in healing and symptomatic relief of duodenal ulcers and erosive or gastroesophageal reflux disease GERD; maintaining healing and reducing relapse rates of heartburn symptoms in patients with GERD; treatment of daytime and nighttime heartburn and other symptoms associated with GERD and in  long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome and in combination with amoxicillin and clarithromycin to eradicate Helicobacter pylori.

India has many manufacturers who manufacture  Rabeprazole sodium  Injection 20 mg.To know more contact us.

3s corporation is Supplier,Exporter ,Wholesaler  for Rabeprazole sodium  Injection 20 mg in India.

Additional Information

Side Effects

Rabeprazole side effects include:

Pack Size